TARO - Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68 revenue of $139.2M misses by $23.92M January, 24 2023 06:03 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical press release ( NYSE: TARO ): Q3 GAAP EPS of $0.19 misses by $0.68 . Revenue of $139.2M misses by $23.92M . For further details see: Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M